Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishnendu Roy

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
International Journal of Oncology|February 14, 2013
Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal antibodyYonghzong Wu, Smitha Antony, Stephen M Hewitt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2013
Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by IFN-γ and lipopolysaccharide in human pancreatic cancer cell linesYongzhong Wu, Jiamo Lu, Smitha Antony, et al.
Cancer|November 7, 2003
Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkersMichele Follen, Frank L Meyskens, Ronald D Alvarez, et al.
Cytotherapy|February 22, 2022
Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipidsS'Dravious A DeVeaux, Molly E Ogle, Sofiya Vyshnya, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Sphingomyelinase Licensing of Mesenchymal Stromal Cells Alters Lipid and Protein Metabolites for ImmunomodulationS'Dravious A DeVeaux, Daniel C Shah, Keji Rui, et al.
Frontiers in Immunology|March 26, 2021
Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A VirusBrock Kingstad-Bakke, Randall Toy, Woojong Lee, et al.
Biomaterials|October 5, 2019
Modification of primary amines to higher order amines reduces in vivo hematological and immunotoxicity of cationic nanocarriers through TLR4 and complement pathwaysRandall Toy, Pallab Pradhan, Vijayeetha Ramesh, et al.
Plos One|May 20, 2020
NADPH oxidase 1 is highly expressed in human large and small bowel cancersJiamo Lu, Guojian Jiang, Yongzhong Wu, et al.
Free Radical Biology & Medicine|June 17, 2023
Exogenous DNA enhances DUOX2 expression and function in human pancreatic cancer cells by activating the cGAS-STING signaling pathwayStephen L Wang, Yongzhong Wu, Mariam Konaté, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2022
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccineAlexandra Atalis, Mark C Keenum, Bhawana Pandey, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
International Journal of Oncology|February 14, 2013
Functional activity and tumor-specific expression of dual oxidase 2 in pancreatic cancer cells and human malignancies characterized with a novel monoclonal antibodyYonghzong Wu, Smitha Antony, Stephen M Hewitt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2013
Activation of TLR4 is required for the synergistic induction of dual oxidase 2 and dual oxidase A2 by IFN-γ and lipopolysaccharide in human pancreatic cancer cell linesYongzhong Wu, Jiamo Lu, Smitha Antony, et al.
Cancer|November 7, 2003
Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkersMichele Follen, Frank L Meyskens, Ronald D Alvarez, et al.
Cytotherapy|February 22, 2022
Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipidsS'Dravious A DeVeaux, Molly E Ogle, Sofiya Vyshnya, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Sphingomyelinase Licensing of Mesenchymal Stromal Cells Alters Lipid and Protein Metabolites for ImmunomodulationS'Dravious A DeVeaux, Daniel C Shah, Keji Rui, et al.
Frontiers in Immunology|March 26, 2021
Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A VirusBrock Kingstad-Bakke, Randall Toy, Woojong Lee, et al.
Biomaterials|October 5, 2019
Modification of primary amines to higher order amines reduces in vivo hematological and immunotoxicity of cationic nanocarriers through TLR4 and complement pathwaysRandall Toy, Pallab Pradhan, Vijayeetha Ramesh, et al.
Plos One|May 20, 2020
NADPH oxidase 1 is highly expressed in human large and small bowel cancersJiamo Lu, Guojian Jiang, Yongzhong Wu, et al.
Free Radical Biology & Medicine|June 17, 2023
Exogenous DNA enhances DUOX2 expression and function in human pancreatic cancer cells by activating the cGAS-STING signaling pathwayStephen L Wang, Yongzhong Wu, Mariam Konaté, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2022
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccineAlexandra Atalis, Mark C Keenum, Bhawana Pandey, et al.
Pageof 16